Marilena Antoniou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marilena Antoniou has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Bastian Bruns
Institute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany
1 shared publicationChristoph Dieterich
Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany
1 shared publicationDana K. Dawson
Cardiology Research Group, Aberdeen Cardiovascular and Diabetes Centre, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK
1 shared publication- Hans-Christoph Friederich
University Hospital Heidelberg
1 shared publication - Heather Marion Wilson
School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
1 shared publication - Hilal Khan
Cardiothoracic Department Freeman Hospital Newcastle upon Tyne UK
1 shared publication
Latest Publications
- Open Access
- 13 July 2023
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 2 (7) , 645-655
Calcineurin signaling promotes takotsubo syndrome
Takotsubo syndrome (TTS) is an acute heart failure syndrome that mimics the symptoms of acute myocardial infarction and is often preceded by emotional and/or physical stress. There is currently no treatment for TTS. Here we show that injection of 2.5 mg kg−1of epinephrine (EPI) into mice recapitulates numerous features of human TTS, including increased myocardial damage and mortality in males. Gene set enrichment analysis of myocardial RNA sequencing after EPI injection revealed significant enrichment of calcineurin-dependent pro-inflammatory gene networks, which was more pronounced in male than in female mice, in agreement with observed sex discrepancies in the mouse phenotype. An increase in calcineurin activity was detected in the circulating cells of patients with TTS, suggesting a systemic nature of the syndrome. Preventive and therapeutic treatment of mice injected with EPI using calcineurin inhibitors cyclosporine and tacrolimus improved heart function and reduced myocardial injury. Our findings suggest that calcineurin inhibition could be a potential therapy for TTS.
- 13 July 2023
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 2 (7) , 645-655
Open AccessCalcineurin signaling promotes takotsubo syndrome
Takotsubo syndrome (TTS) is an acute heart failure syndrome that mimics the symptoms of acute myocardial infarction and is often preceded by emotional and/or physical stress. There is currently no treatment for TTS. Here we show that injection of 2.5 mg kg−1of epinephrine (EPI) into mice recapitulates numerous features of human TTS, including increased myocardial damage and mortality in males. Gene set enrichment analysis of myocardial RNA sequencing after EPI injection revealed significant enrichment of calcineurin-dependent pro-inflammatory gene networks, which was more pronounced in male than in female mice, in agreement with observed sex discrepancies in the mouse phenotype. An increase in calcineurin activity was detected in the circulating cells of patients with TTS, suggesting a systemic nature of the syndrome. Preventive and therapeutic treatment of mice injected with EPI using calcineurin inhibitors cyclosporine and tacrolimus improved heart function and reduced myocardial injury. Our findings suggest that calcineurin inhibition could be a potential therapy for TTS.